AGÕæÈ˹ٷ½

STOCK TITAN

Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Labcorp (NYSE: LH), a leading provider of innovative laboratory services, has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company's executive management team will engage in a fireside chat on Tuesday, September 9, at 7:45 am ET.

Investors and interested parties can access a live audio webcast of the presentation through Labcorp's investor relations website at ir.Labcorp.com. The presentation will also be archived for future replay.

Labcorp (NYSE: LH), fornitore leader di servizi di laboratorio innovativi, ha annunciato la sua partecipazione al Morgan Stanley 23rd Annual Global Healthcare Conference. Il team di gestione esecutiva dell'azienda parteciperà a una fireside chat il martedì 9 settembre, alle 7:45 ET.

Investitori e parti interessate potranno seguire la presentazione in diretta audio tramite webcast sul sito per gli investitori di Labcorp all'indirizzo ir.Labcorp.com. La presentazione sarà inoltre archiviata per la visione in replay.

Labcorp (NYSE: LH), proveedor líder de servicios de laboratorio innovadores, ha anunciado su participación en la Morgan Stanley 23rd Annual Global Healthcare Conference. El equipo directivo de la compañía participará en una charla informal el martes 9 de septiembre a las 7:45 am ET.

Los inversores y las personas interesadas podrán acceder a la retransmisión de audio en directo de la presentación a través del sitio web de relaciones con inversores de Labcorp en ir.Labcorp.com. La presentación también quedará archivada para reproducción posterior.

Labcorp (NYSE: LH)ëŠ� í˜ì‹ ì ì¸ ê²€ì‚� ì„œë¹„ìŠ¤ì˜ ì„ ë„업체로서 Morgan Stanley 23rd Annual Global Healthcare Conferenceì—� 참여한다ê³� 발표했습니다. 회사ì� ê²½ì˜ì§„ì´ 9ì›� 9ì� 화요ì� ë™ë¶€ 시간 오전 7ì‹� 45ë¶�ì—� 파ì´ì–´ì‚¬ì´ë“œ 채팅ì—� 참여합니ë‹�.

투ìžìžì™€ ê´€ì‹� 있는 ë¶„ë“¤ì€ Labcorp 투ìžìž� ê´€ê³� 웹사ì´íЏì� ir.Labcorp.comì� 통해 프레젠테ì´ì…˜ 오디ì˜� ë¼ì´ë¸� 웹ìºìŠ¤íŠ¸ë¥� 시청í•� ìˆ� 있습니다. 해당 발표ëŠ� ì´í›„ 재청취할 ìˆ� 있ë„ë¡� ì•„ì¹´ì´ë¸Œì—ë„ ì €ìž¥ë©ë‹ˆë‹¤.

Labcorp (NYSE: LH), fournisseur de premier plan de services de laboratoire innovants, a annoncé sa participation à la Morgan Stanley 23rd Annual Global Healthcare Conference. L'équipe de direction de la société participera à une conversation informelle le mardi 9 septembre à 7h45 ET.

Les investisseurs et les personnes intéressées peuvent accéder à la webdiffusion audio en direct de la présentation via le site relations investisseurs de Labcorp à ir.Labcorp.com. La présentation sera également archivée pour une lecture ultérieure.

Labcorp (NYSE: LH), ein führender Anbieter innovativer Labordienstleistungen, hat seine Teilnahme an der Morgan Stanley 23rd Annual Global Healthcare Conference angekündigt. Das Management-Team des Unternehmens wird am Dienstag, 9. September, um 7:45 Uhr ET an einem Fireside-Chat teilnehmen.

Investoren und Interessierte können die Präsentation als Live-Audio-Webcast über die Investor-Relations-Website von Labcorp unter ir.Labcorp.com verfolgen. Die Präsentation wird zudem für eine spätere Wiedergabe archiviert.

Positive
  • None.
Negative
  • None.

BURLINGTON, N.C., Aug. 27, 2025 /PRNewswire/ --  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, Sept. 9, at 7:45 am ET.

A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay. 

About Labcorp
³¢²¹²ú³¦´Ç°ù±èÌý(±·³Û³§·¡: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 million tests annually for patients around the world. Learn more about us at

Cision View original content to download multimedia:

SOURCE Labcorp Holdings Inc

FAQ

When is Labcorp (LH) presenting at the Morgan Stanley Healthcare Conference 2025?

Labcorp will present at the conference on Tuesday, September 9, 2025 at 7:45 am ET.

How can I watch Labcorp's presentation at the Morgan Stanley Healthcare Conference?

The presentation can be accessed via live audio webcast through Labcorp's investor relations website at ir.Labcorp.com. It will also be archived for replay.

What type of presentation will Labcorp (LH) give at the Morgan Stanley conference?

Labcorp's executive management team will participate in a fireside chat format presentation.

Where can I find the replay of Labcorp's Morgan Stanley conference presentation?

The presentation replay will be available on Labcorp's investor relations website at ir.Labcorp.com after the live event.
Labcorp Holdings Inc

NYSE:LH

LH Rankings

LH Latest News

LH Latest SEC Filings

LH Stock Data

22.94B
82.77M
0.34%
99.89%
3.31%
Diagnostics & Research
Services-medical Laboratories
United States
BURLINGTON